BioSpace News Archive

Business

Devyser Diagnostics AB publishes quarterly report for the period January to March 2023

The first quarter of the year saw continued strong growth, record gross margin and the launching of our first IVDR-approved product.

May 9, 2023
·
3 min read
Business

ERYTECH Provides Business and Financial Update for the First Quarter of 2023

ERYTECH Pharma,aclinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, provided a business and financial updatefor thefirst quarter of 2023.

May 9, 2023
·
10 min read
Business

Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the first quarter ended March 31, 2023, and provides a corporate update.

May 9, 2023
·
12 min read
Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor

Zion Pharma Limited, a Chinese biotechnology company focused on the development of brain-penetrable compounds, announced that Roche has acquired the global rights to Zion’s lead program, ZN-A-1041.

May 9, 2023
·
3 min read
Drug Development

PureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week

PureTech Health plc announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to Vedanta’s defined bacterial consortium candidate, VE303, for the prevention of recurrent Clostridioides difficile infection (rCDI).

May 9, 2023
·
12 min read
Business

Spago Nanomedical Interim Report January-March 2023

Spago Nanomedical Towards clinic with Tumorad®

May 9, 2023
·
5 min read
Genetown

Biophytis has Requested a Pre-Submission Meeting with the EMA for the Marketing Authorisation of Sarconeos (BIO101) for the Treatment of COVID-19

Biophytis SA announced that it has filed for a pre-submission meeting request with the European Medicine Agency to discuss filing for conditional Marketing Authorisation in Europe for Sarconeos in the treatment of severe form of COVID-19.

May 9, 2023
·
4 min read
Business

Sigrid Therapeutics announces appointment of distinguished Professor Iain Chapple to Scientific Advisory Board

Sigrid Therapeutics (Sigrid), a Swedish consumer-centric Healthtech company today announced it has appointed world-leading oral health expert Professor Iain Chapple from the University of Birmingham’s College of Medical and Dental Sciences to its Scientific Advisory Board.

May 9, 2023
·
2 min read
Neuboron Medical Group and Xiamen Humanity Hospital Make ‘Grand Debut’ at Xiamen BNCT Tech Forum to Drive Clinical Application and New Drug Development

On April 22, Neuboron Medical Group, a leading global Accelerator-based Boron Neutron Capture Therapy total solution provider, and Xiamen Humanity Hospital collaborated to co-host the Xiamen BNCT Technology Forum 2023 at the BNCT center in XHH.

May 9, 2023
·
4 min read
BioNxt Successfully Completes Pilot Study for Contract Development Customer

BioNxt Solutions Inc. is pleased to announce that it has successfully completed a human pilot study for a leading European-based generic drug company.

May 9, 2023
·
3 min read